Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Revenue 2017–2025
Aquestive Therapeutics Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aquestive Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 14.4 M, a 65.67% increase year-over-year.
- Aquestive Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 46.0 M, a 21.67% decrease year-over-year.
- Aquestive Therapeutics Inc. annual revenue for 2025 was 44.5 M, a 22.61% decrease from 2024.
- Aquestive Therapeutics Inc. annual revenue for 2024 was 57.6 M, a 13.80% increase from 2023.
- Aquestive Therapeutics Inc. annual revenue for 2023 was 50.6 M, a 6.09% increase from 2022.
- Aquestive Therapeutics Inc. annual revenue for 2022 was 47.7 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aquestive Therapeutics Inc. Market Cap — FAQ
Aquestive Therapeutics Inc. (AQST) market cap over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AQST's market cap history?
The chart and table above show Aquestive Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.